Neuropilin‐1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1-Reference-Cited by-同舟云学术

Neuropilin‐1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1

Published:2021-08-27 Issue:1 Volume:289 Page:183-198
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:The FEBS Journal

Author:

Colotti Gianni¹,Failla Cristina Maria²,Lacal Pedro Miguel³,Ungarelli Mariangela⁴,Ruffini Federica³,Di Micco Patrizio⁵,Orecchia Angela⁴,Morea Veronica¹^ORCID

Affiliation:

1. Institute of Molecular Biology and Pathology (IBPM) of the National Research Council (CNR) Rome Italy

2. Laboratory of Experimental Immunology IDI‐IRCCS Rome Italy

3. Laboratory of Molecular Oncology IDI‐IRCCS Rome Italy

4. Laboratory of Molecular and Cell Biology IDI‐IRCCS Rome Italy

5. Department of Biochemical Sciences ‘A. Rossi Fanelli’ Sapienza’ University of Rome Italy

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.16119

Reference55 articles.

1. Determination of Cell Adhesion Sites of Neuropilin-1

2. Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III

3. Neuropilin Is a Semaphorin III Receptor

4. Neuropilin-1 Is a Placenta Growth Factor-2 Receptor

5. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Endothelial Cell Is Not Simply an Endothelial Cell;Stem Cells and Development;2024-08-09

2. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis;International Journal of Molecular Sciences;2024-04-25

3. Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction;Cell Communication and Signaling;2023-10-30

4. The Nervous System Development Regulator Neuropilin-1 as a Potential Prognostic Marker and Therapeutic Target in Brain Cancer;Cancers;2023-10-10

5. Insight into the mechanism of CD34⁺ cell mobilisation impairment in multiple myeloma patients treated with anti‐CD38 therapy;British Journal of Haematology;2023-10-09